We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Entegris
ENTG
$23B
| $3.76M | 0.01% |
40,925
+9,331
| +30% | +$1.01M |
|
877
Perdoceo Education
PRDO
$1.95B
| $3.73M | 0.01% |
316,756
+74,503
| +31% | +$816K |
|
878
Teladoc Health
TDOC
$1.24B
| $3.72M | 0.01% |
115,174
+75,028
| +187% | +$3.19M |
|
879
SiriusXM
SIRI
$9.61B
| $3.72M | 0.01% |
61,172
+3,613
| +6% | +$224K |
|
|
EXE
880
Expand Energy Corp
EXE
$22.7B
| $3.71M | 0.01% |
45,734
+7,855
| +21% | +$710K |
|
|
WIRE
881
DELISTED
Encore Wire Corp
WIRE
| $3.7M | 0.01% |
35,588
+2,176
| +7% | +$257K |
|
882
CVR Energy
CVI
$3.42B
| $3.68M | 0.01% |
109,846
+50,628
| +85% | +$1.62M |
|
883
Papa John's
PZZA
$801M
| $3.67M | 0.01% |
43,970
-47,554
| -52% | -$4.28M |
|
|
PDM
884
Piedmont Realty Trust
PDM
$1.17B
| $3.67M | 0.01% |
279,821
+70,975
| +34% | +$1.07M |
|
885
Kirby Corp
KEX
$7B
| $3.66M | 0.01% |
60,781
+34,478
| +131% | +$2.24M |
|
886
Qiagen
QGEN
$8.81B
| $3.66M | 0.01% |
73,078
+6,677
| +10% | +$326K |
|
887
Photronics
PLAB
$1.95B
| $3.64M | 0.01% |
187,049
-8,858
| -5% | -$155K |
|
888
DexCom
DXCM
$33.8B
| $3.63M | 0.01% |
48,971
+8,631
| +21% | +$788K |
|
889
Antero Resources
AR
$11.6B
| $3.61M | 0.01% |
117,748
-129,831
| -52% | -$4.75M |
|
890
Newell Brands
NWL
$2.62B
| $3.6M | 0.01% |
190,613
+22,205
| +13% | +$472K |
|
891
Alector
ALEC
$233M
| $3.58M | 0.01% |
352,531
+186,243
| +112% | +$1.86M |
|
892
Intrepid Potash
IPI
$496M
| $3.58M | 0.01% |
79,058
+57,514
| +267% | +$4.19M |
|
893
Midland States Bancorp
MSBI
$692M
| $3.54M | 0.01% |
147,370
+43,741
| +42% | +$1.14M |
|
894
Regenxbio
RGNX
$703M
| $3.53M | 0.01% |
143,065
+102,574
| +253% | +$2.56M |
|
895
Globant
GLOB
$1.68B
| $3.53M | 0.01% |
20,510
+483
| +2% | +$98.3K |
|
896
Grupo Aeroportuario Centro Norte
OMAB
$5.23B
| $3.52M | 0.01% |
68,815
+7,267
| +12% | +$414K |
|
897
Rush Enterprises Class A
RUSHA
$9.52B
| $3.52M | 0.01% |
109,674
-21,935
| -17% | -$733K |
|
898
Prestige Consumer Healthcare
PBH
$2.54B
| $3.52M | 0.01% |
62,281
+4,536
| +8% | +$250K |
|
899
Titan Machinery
TITN
$438M
| $3.52M | 0.01% |
157,159
+58,364
| +59% | +$1.46M |
|
900
Axalta
AXTA
$7.98B
| $3.51M | 0.01% |
158,822
-260,146
| -62% | -$6.61M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.